CohBar Investor Relations Material
Latest events
M&A Announcement
CohBar
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from CohBar Inc
Access all reports
CohBar, Inc. is a clinical stage biotechnology company based in California that focuses on the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company's platform technology involves improving cellular metabolism to enhance healthy biological aging through encapsulation of mitochondria within multifunctional liposomes. Cohbar's sales channels are through direct sales and through distributors who are licensed to market its products both domestically and internationally.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
CWBR
Country
đșđž United States